There appears to be a gender-based difference in the beneficial effect of aspirin.
Right now the emphasis seems to be on asset price deflation. The key questions concern just how far these markets can correct and whether there will be a domino effect as other markets are affected.
In women aspirin prevents strokes and doesn't have any real effect on heart attack, and in men aspirin prevents heart attacks, but has no effect on the prevention of strokes.